Taylar et al. first reported the relationship between Zn and tamoxifen resistance therapeutic strategy and indicated that SLC39A7 is abundantly expressed in a BC cell line - tamoxifen-resistant MCF7 [44]. This evidence concerns the gene SLC39A7 and breast cancer.